Bristol-Myers Squibb (BMS) Oncology Drugs To Account For 66% of The Company's Total Sales In 2020, And It Is Also The Key To The Near Term Revenue Growth
Oncology drugs expected to be the single-biggest revenue driver with $27.7 billion in revenues (66% of Total Revenues), which is over 3x the size of Cardiovascular, BMS' second largest business segment, in 2020.Oncology drugs, which includes blockbuster drugs Revlimid and Opdivo, among other drugs, will be the fastest-growing segment - adding $19.2 billion over 2017-20 (90% of $21.3 billion in incremental revenues). Cardiovascular, which includes Eliquis, will add about $4.1 billion over 2017-20 (19% of the $11.5 billion in incremental revenue), and Immunology will add $1.0 billion (5% of incremental revenues). All Others to add $(3.0) billion.
Total Revenues
What Is Big?
1. Oncology: $27.7 Bil (66%)
2. Cardiovascular: $9.0 Bil (21%)
3. Immunology: $3.5 Bil (8%)
4. All Others: $1.9 Bil (5%)
---------------------------------------------------------------------------
Total Expected Revenue In 2020 $42.1 Bil
What Has Changed?
From 2017 To 2020E
Oncology: $19.2 Bil
+ Cardiovascular: $4.1 Bil
+ Immunology: $1.0 Bil
+ All Others: $(3.0) Bil
--------------------------------------------------------------------
Total Change 2017-2020E: $21.3 Bil
+ BMS' Revenue In 2017: $20.8 Bil
= Total Revenue In 2020E: $42.1 Bil
Bristol-Myers Squibb's Business Model
What Need Does It Serve?
Brisol-Myers Squibb is a biopharmaceutical company that discovers, develops, and sells pharmaceutical products globally. Its drugs are used for the treatment of various types of diseases, including cancer, heart-related, and infectious, among others.
Overall, the company's pharmaceuticals portfolio can be divided into 5 segments, primarily on the basis of therapeutic areas: 1) Cardiovascular, 2)Oncology, 3) Virology, 4) Immunology, and 5) Mature Products & Others.
Who Pays To Bristol-Myers Squibb?
Chain stores (Walgreens, CVS, Rite-Aid, Walmart), clinics, long term care facilities, health maintenance organizations, federal facilities, non-federal institutions, and mail order pharmacies.
What Are The Alternatives To Bristol-Myers Squibb?
Within pharmaceuticals, other alternatives are Johnson & Johnson, Roche, Pfizer, Merck, Abbvie, GlaxoSmithKline, and Teva, among others.
Outside of pharmaceuticals, other alternatives are acupuncture, aromatherapy, ayurvedic medicine, chiropractic care, homeopathy, and nutritional counseling, among others.
Disagree With Our Forecasts? Create Your Own
1. How to save your forecasts for Bristol-Myers Squibb:
Click on the blue "Try Trefis" button in the header to create an account, then navigate back to this dashboard. Now, any changes you make to these inputs will be auto-saved as a scenario (see left panel of dashboard).
2. How to monitor your scenario vs. actual results
Once you've saved your forecast, you can "rename" your scenario by clicking on the gear icon next to the scenario (on the left panel). For more info, see this quick, 30-sec video (look at the 9 sec mark)
With your forecast saved and named, you can see how well you forecast the company's performance at the end of each period and compare your forecasts to hundreds of other Trefis users who came up with their own forecasts.
Lastly, you can share with friends and colleagues to show them how you fared and compare your forecasts to theirs.